WEST PHARMACEUTICAL SVSC INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 352,838 | $78,993,371 | 0.22% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 366,152 | $80,114,086 | 0.21% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2025 |
| Sept. 30, 2025 | 40,805 | $10,704,439 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 41,242 | $11,347,420 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 9, 2026 |
| March 31, 2026 | 39,725 | $9,956,795 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2026 |
| June 30, 2026 | 417,309 | $149,813,786 | 0.45% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.